Aprecap Vial (Fosaprepitant Dimeglumine Vials) 150mg

Aprecap Vial contains fosaprepitant dimeglumine, a neurokinin-1 receptor antagonist used to prevent chemotherapy-induced nausea and vomiting. This 150mg injectable vial is commonly prescribed alongside other antiemetic medications. Aprecap Vial is manufactured by Glenmark Pharmaceuticals Ltd and is available in India.

Strength

150mg

Manufacturer / TM Owner

Glenmark Pharmaceuticals Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fosaprepitant dimeglumine, the active ingredient in Aprecap Vial, is primarily used to prevent nausea and vomiting caused by chemotherapy treatments. It works by blocking a natural substance in the body that triggers vomiting. This medication is often prescribed for patients receiving highly emetogenic chemotherapy regimens. Aprecap Vial may also be used for other conditions as determined by a healthcare provider.

Side Effects

Aprecap Vial helps reduce the likelihood of nausea and vomiting during and after chemotherapy. Patients may experience improved comfort and ability to maintain hydration and nutrition during treatment. The effects of this medication are typically noticeable within the first few days following administration. Individual responses may vary based on the chemotherapy regimen and personal health factors.

Precautions & Warnings

Aprecap Vial should be handled and administered by a healthcare professional. Patients with a history of allergic reactions to fosaprepitant or similar medications should inform their doctor before use. It is important to disclose all current medications and health conditions to the prescribing physician. Keep this medication stored in a controlled environment as directed by the manufacturer.

Avoid Interactions

Aprecap Vial may interact with other medications, including certain antibiotics, antifungals, and blood thinners. Combining this medication with alcohol or sedatives could increase drowsiness. Patients taking CYP3A4 inhibitors or inducers may require dose adjustments. Always consult a healthcare provider about potential drug interactions before starting treatment.

References

Frequently Asked Questions

Fosaprepitant dimeglumine is used to prevent nausea and vomiting caused by chemotherapy treatments.

Aprecap Vial is administered as an injection by a healthcare professional, typically before chemotherapy begins.

Aprecap Vial is a prescription medication and availability may vary by region and pharmacy policies.

Common side effects may include headache, fatigue, or digestive discomfort.

Aprecap Vial should only be used under medical supervision and may not be suitable for patients with certain health conditions.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.